chr18-657443-A-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000701410.1(TYMSOS):​n.154T>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.665 in 151,974 control chromosomes in the GnomAD database, including 34,158 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 34158 hom., cov: 30)

Consequence

TYMSOS
ENST00000701410.1 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.655

Publications

7 publications found
Variant links:
Genes affected
TYMSOS (HGNC:29553): (TYMS opposite strand RNA)
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000701410.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.716 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000701410.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMSOS
NR_171001.1
n.450+399T>G
intron
N/A
TYMS
NM_001071.4
MANE Select
c.-300A>C
upstream_gene
N/ANP_001062.1Q53Y97
TYMS
NM_001354867.2
c.-300A>C
upstream_gene
N/ANP_001341796.1P04818-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYMSOS
ENST00000323813.6
TSL:1
n.511+399T>G
intron
N/A
TYMSOS
ENST00000701410.1
n.154T>G
non_coding_transcript_exon
Exon 1 of 2
TYMSOS
ENST00000585033.1
TSL:2
n.428+399T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.665
AC:
101030
AN:
151856
Hom.:
34123
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.543
Gnomad AMI
AF:
0.786
Gnomad AMR
AF:
0.726
Gnomad ASJ
AF:
0.724
Gnomad EAS
AF:
0.519
Gnomad SAS
AF:
0.651
Gnomad FIN
AF:
0.741
Gnomad MID
AF:
0.652
Gnomad NFE
AF:
0.721
Gnomad OTH
AF:
0.679
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.665
AC:
101115
AN:
151974
Hom.:
34158
Cov.:
30
AF XY:
0.668
AC XY:
49644
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.543
AC:
22523
AN:
41446
American (AMR)
AF:
0.726
AC:
11096
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.724
AC:
2512
AN:
3468
East Asian (EAS)
AF:
0.520
AC:
2670
AN:
5134
South Asian (SAS)
AF:
0.650
AC:
3125
AN:
4804
European-Finnish (FIN)
AF:
0.741
AC:
7837
AN:
10574
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.721
AC:
49019
AN:
67958
Other (OTH)
AF:
0.673
AC:
1421
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1701
3402
5104
6805
8506
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.604
Hom.:
2482
Bravo
AF:
0.657
Asia WGS
AF:
0.579
AC:
2012
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.97
DANN
Benign
0.47
PhyloP100
-0.66
PromoterAI
-0.0016
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2606241;
hg19: chr18-657443;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.